Evidence map›Paper›PMID 35028473›Full record

ArticleHeliyon2022

Towards a 'wide' role for venture capital in OECD countries' industry 4.0.

Bruno S Sergi, Elena G Popkova

Abstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bruno S SergiHarvard University, USA.
Elena G PopkovaMoscow State Institute of International Relations (MGIMO University), Moscow, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper focuses on the current theoretical views of venture capital that predetermines a "narrow" treatment. In the light of the existing "narrow" treatment, venture investors seek private commercial interests in financial support for Industry 4.0, ignoring other interests that fall beyond the limits of the current "narrow" treatment of venture capital. A "wide" treatment of venture capital 4.0 proposed in this paper allows for improving venture investors' market strategies. Implementing this treatment, they will strive for providing a whole range of advantages for society. Due to this novel approach, venture capital 4.0 might become a tool of corporate social responsibility. To substantiate this novel approach, this paper considers data for 2020 that reflect the influence of venture capital 4.0 on the economy in the period of its stability for 33 countries of the OECD, including developed and developing countries. Econometric modelling based on the official statistics data proves that Industry 4.0 venture capital will help achieve such growth goals as innovative development, global competitiveness, and increasing digital competitiveness. The limitations of this research are due to the impossibility of achieving such goals as sustainable development, economic growth, and implementation of human potential; what's more, the specifics of developing countries have not been studied sufficiently. The conclusions are oriented mainly at developed countries and could merely partially be applied to developing countries. During further research, it is expedient to explore - more thoroughly - the experience of the influence of Industry 4.0 venture capital on emerging economies.

Indexed as

CompetitivenessDigital technologiesIndustry 4.0Venture capital

Identifiers

PMID35028473
PMCPMC8741461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.